DealBio
All collections

Investor Intelligence

11 Medical Imaging Investors in the US

Medical-imaging investors with demonstrated activity across MRI, ultrasound, AI-assisted imaging and diagnostic devices in the United States.

Published
  • Medical Imaging
  • Medical Devices
  • Diagnostics
  • United States
  • Seed
  • Series A

Medical imaging sits at the intersection of regulated hardware, clinical workflow, specialised data and increasingly sophisticated software. That combination creates a distinctive financing problem: investors need to underwrite technical risk, clinical evidence, regulatory strategy and hospital adoption while still supporting companies early enough for venture-scale upside.

DealBio selected 11 investors with evidenced relevance to early-stage medical imaging in the United States, using current investor research, financing precedents and public verification where needed.

S3 Ventures

Texas-born venture firm investing nationally across healthcare technology and business software.

Stage
Seed · Series A · Series B
Sector / Focus
Medical imaging · Medtech · Healthcare technology
Investment markets
United States
Investor type
VC

Relevant investment

S3 Ventures co-led MaxQ Medical’s $31.5 million Series A in August 2026. MaxQ is developing a ultrasound imaging and therapy system for prostate care, giving S3 direct exposure to a clinically specialised imaging platform moving through clinical development.

DCVC

Deep-tech venture firm backing companies that apply advanced computing and engineering to large industries.

Stage
Seed · Series A · Growth
Sector / Focus
AI imaging · Medical imaging · Deep tech
Investment markets
United States
Investor type
VC

Relevant investment

DCVC was an early investor in Subtle Medical, participating in its $1.1 million seed financing. Subtle Medical develops AI software that improves , and image quality and scan efficiency, linking DCVC’s deep-compute thesis directly to clinical imaging workflows.

Dolby Family Ventures

Early-stage investor focused on science, engineering and technologies with the potential to reshape major markets.

Stage
Seed · Series A
Sector / Focus
Medical imaging · Deep tech · Healthcare
Investment markets
United States
Investor type
Family-backed VC

Relevant investment

Dolby Family Ventures backed Hyperfine, developer of a portable designed to bring brain imaging closer to the point of care. The investment is relevant to capital-efficient imaging hardware that challenges the traditional fixed MRI suite model.

Zynext Ventures

Healthcare venture arm of Zydus Lifesciences investing in seed and early-stage biotech and health technologies.

Stage
Seed · Early stage
Sector / Focus
Medical imaging · Diagnostics · Healthcare technology
Investment markets
United States · Global
Investor type
Corporate VC

Relevant investment

Zynext Ventures has invested in compact-MRI companies including Promaxo and neuro42. Promaxo is developing an in-office MRI platform with an early focus on prostate imaging, while neuro42 combines portable MRI with image-guided neurosurgical robotics; disclosed round amounts were not confirmed in the sources used for this article.

cultivate(MD)

Specialist medical-device venture fund investing in technologies intended to improve outcomes and reduce healthcare costs.

Stage
Early stage · Series A
Sector / Focus
Medical devices · MRI · Diagnostics
Investment markets
United States
Investor type
VC

Relevant investment

cultivate(MD) co-led SpinTech MRI’s $6.5 million Series A in 2022. SpinTech’s software is designed to speed and improve neurological imaging analysis, providing a direct medical-imaging software precedent.

Sonder Capital

Healthcare venture firm focused on technologies that can establish new standards of care.

Stage
Early stage
Sector / Focus
Medtech · Medical imaging · Diagnostics
Investment markets
United States
Investor type
VC

Relevant investment

Sonder Capital backs Ziteo, which is developing imaging technology for tumour detection and surgical decision support. The financing amount was not publicly disclosed in the sources reviewed, but the investment gives Sonder direct exposure to image-based cancer detection and intervention.

SHD Partners

Early-stage healthcare investor with a focus on medical technologies and clinically differentiated devices.

Stage
Seed · Early stage
Sector / Focus
Urology · Medical imaging · Medtech
Investment markets
United States
Investor type
VC

Relevant investment

SHD Partners participated in Urologic Health’s $11 million seed financing in 2026. The company is building technology for urologic diagnosis and treatment, making the deal relevant to imaging-led and procedure-oriented platforms addressing specialised clinical workflows.

Healthier Capital

Healthcare-focused venture firm founded by former One Medical CEO Amir Dan Rubin.

Stage
Early stage · Growth
Sector / Focus
Healthcare technology · Imaging · Preventive health
Investment markets
United States
Investor type
VC

Relevant investment

Healthier Capital co-led Ezra’s $21 million financing in February 2024. Ezra combines full-body MRI with FDA-cleared AI to reduce scan time and expand access to cancer screening, giving Healthier Capital a direct precedent in consumer-facing imaging infrastructure.

LDV Capital

Thesis-driven early-stage investor focused on businesses powered by visual technology and AI.

Stage
Pre-incorporation · Pre-seed · Seed
Sector / Focus
Computer vision · AI · Medical imaging
Investment markets
United States · Europe
Investor type
VC

Relevant investment

LDV Capital invested in Ezra before its Series A. Ezra’s first institutional round raised $4 million for an MRI-based cancer-screening model, and LDV later remained an investor as the company expanded its AI imaging stack and scan network.

ShangBay Capital

Palo Alto venture firm specialising in early-stage medical devices, biotechnology and digital health.

Stage
Seed · Series A
Sector / Focus
Medical devices · Portable MRI · Medtech
Investment markets
United States
Investor type
VC

Relevant investment

ShangBay Capital participated in neuro42’s $6.5 million Series A in 2021. neuro42 is developing portable MRI and robotics for neurological diagnosis and image-guided intervention, a close financing precedent for specialised imaging hardware.

Catalyst Health Ventures

Early-stage MedTech investor focused on therapeutic devices, diagnostic devices and digital-health technologies.

Stage
Early stage · Follow-on
Sector / Focus
Diagnostics · Medical devices · Medtech
Investment markets
United States
Investor type
VC

Relevant investment

Catalyst Health Ventures invests exclusively in medical technology and has backed diagnostic-device businesses including Allegro Diagnostics and Sera Prognostics. Its strategy is relevant to imaging founders because the firm explicitly targets early technologies with clear regulatory pathways and follows companies through commercialisation.

Methodology

DealBio builds investor lists using structured investor research, demonstrated investment activity and current public verification where needed. The methodology highlights investors with evidenced relevance to the article’s sector, stage and geography.

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.